Aslan Pharmaceuticals | 6-K: Report of foreign private issuer (related to financial reporting)
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Related Stocks Related Stocks
Symbol Mini Chart Latest Price
Unlock the Full List
Latest
09:19
China International Capital Corporation: The strength of commercial aerospace is expected to accelerate the deployment process of low-orbit internet plus-related.
CICC0.00%
09:17
The central parity rate of the RMB is reported at 7.1996, down 131 points, while the previous trading day's central parity rate was 7.1865, and the onshore RMB closed at 7.2706 in the last trading session.
09:15
The central parity rate of RMB against the US dollar is reported at 7.1996 yuan.